Diethylamine

Diethylamine

SCHEMBL21145244

CCNCC.O=C(O)CO

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.50
FFAR3 O14843 2/20 0.44
LDHA P00338 1/20 0.39
SRR Q9GZT4 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
OR51E2 Q9H255 2/20 0.33
MCL1 Q07820 1/20 0.33
AKR1B1 P15121 1/20 0.33
GPR84 Q9NQS5 7/20 0.32
PPARG P37231 7/20 0.32
PPARD Q03181 7/20 0.32
PPARA Q07869 7/20 0.32
HDAC11 Q96DB2 5/20 0.32
TSHR P16473 4/20 0.32
PTPN1 P18031 3/20 0.32
ALDH1A1 P00352 2/20 0.32
TLR2 O60603 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL28428410 0.84 FFAR3 (0.67) TP53FFAR3LDHASRRHDAC3
Propionic Acid SCHEMBL1014332 0.84 FFAR3 (0.67) TP53FFAR3LDHASRRHDAC3
Malonic Acid SCHEMBL5874776 0.84 LDHA (0.60) TP53FFAR3LDHASRRHDAC3
Malonic Acid SCHEMBL5874780 0.84 LDHA (0.60) TP53FFAR3LDHASRRHDAC3
Diethylamine SCHEMBL5874292 0.83 TP53 (0.61) TP53FFAR3LDHASRRHDAC3
Diethylamine SCHEMBL4340639 0.83
Succinic Acid SCHEMBL5874535 0.81 EGLN1 (0.56) TP53FFAR3HDAC3HDAC1HDAC2
Propionic Acid SCHEMBL9094207 0.81 FFAR3 (0.62) TP53FFAR3LDHASRRHDAC3
Succinic Acid SCHEMBL5874529 0.81 EGLN1 (0.56) TP53FFAR3HDAC3HDAC1HDAC2
Diethylamine SCHEMBL28289500 0.81 TP53 (0.50) TP53FFAR3LDHASRRHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200179254-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2020-06-11 US disclosed
US-20190240129-A1 CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2019-08-08 US disclosed
US-20190216703-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2019-07-18 US disclosed
US-20190216714-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2019-07-18 US disclosed
CN-102762534-A Aryl sulfone derivatives as calcium channel blockers ZALICUS PHARMACEUTICALS LTD 2012-10-31 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190240129-A1 CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, CUTA, S100A10 TP53 2105/4885FFAR3 2270/4885LDHA 1505/4885
US-20190216703-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, SRRM2, IK TP53 2548/4885FFAR3 1837/4885LDHA 3651/4885
US-20190216714-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, CD44, PCNA TP53 1209/4885FFAR3 3218/4885LDHA 1635/4885
US-20200179254-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, CUTA, DSG1 TP53 1442/4885FFAR3 2914/4885LDHA 2216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.